Collective2 Collective2

Welcome to Collective2

Follow these tips for a better experience

Ok, let's start

Close
Add to Watch List Create new Watch List
Add
Enter a name for your Watch List.
Watch List name must be less than 60 characters.
You have reached the maximum number of custom Watch Lists.
You have reached the maximum number of strategies in this Watch List.
Strategy added to Watch List. Go to Watch List

Sim is unavailable for this strategy, because you've recently "Simmed" it.

You already have a live, full-featured subscription to this strategy.

Okay, no problem

Reach out to us when you are ready. You can schedule your free training session at any time by clicking the button.

Remember, this training is free, low pressure, and (we hope!) fun.

Got it

Later

You can find it here.

Got it

Video Saved for Later

You can watch this video later. Just click this button at the top of the screen whenever you're ready to watch it.

Got it

THE SUBSCRIBER PERSPECTIVE

Strategy reviews

Real experiences. In subscribers' own words.

Read what worked, what didn't, and what it was like to follow a strategy.

Your review invitations
Clear filters Newest first

Reviews of GSK

GSK

Not sure how serious this vendor is. Systems changes frequently and is interrupted by substantial periods of no trading activity. Last change was made after system experienced largest historical draw down when vendor kept averaging down into losing position
Subscriber review · Published anonymouslyMore for this strategy